News

Printer Friendly Version View printer-friendly version
<< Back
Array CEO Robert E. Conway to Speak at BIO CEO & Investor Conference

BOULDER, Colo., Feb. 10 /PRNewswire-FirstCall/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the BIO CEO & Investor Conference on February 24 in New York City.

     Event:          BIO CEO & Investor Conference
     Presentation:   "The Early Bird Gets the Worm -- The Re-emergence of
                      Pharma's Interest in Early Stage Compounds"
     Panelist:       Robert E. Conway, Chief Executive Officer,
                      Array BioPharma
     Date:           Tuesday, February 24, 2004
     Time:           11:00 a.m. Eastern Time
     Location:       Waldorf-Astoria Hotel, New York City

About Array BioPharma:

Array BioPharma is creating the next generation of orally active drugs by integrating the latest advances in chemistry, biology and informatics. Our drug development pipeline is focused primarily in cancer and inflammatory disease and includes many promising small molecule drugs that affect disease pathways with well-validated targets. Array also collaborates with leading pharmaceutical and biotechnology companies to invent and optimize drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com .

SOURCE Array BioPharma Inc.

-0-

02/10/2004

/CONTACT:
Tricia Haugeto of Array BioPharma Inc., +1-303-386-1193, thaugeto@arraybiopharma.com/

/Web site: http://www.arraybiopharma.com / (ARRY)

http://www.prnewswire.com